1. Home
  2. EBS vs DFP Comparison

EBS vs DFP Comparison

Compare EBS & DFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • DFP
  • Stock Information
  • Founded
  • EBS 1998
  • DFP 2013
  • Country
  • EBS United States
  • DFP United States
  • Employees
  • EBS N/A
  • DFP N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • DFP Investment Managers
  • Sector
  • EBS Health Care
  • DFP Finance
  • Exchange
  • EBS Nasdaq
  • DFP Nasdaq
  • Market Cap
  • EBS 423.6M
  • DFP 436.6M
  • IPO Year
  • EBS 2006
  • DFP N/A
  • Fundamental
  • Price
  • EBS $9.14
  • DFP $21.89
  • Analyst Decision
  • EBS Strong Buy
  • DFP
  • Analyst Count
  • EBS 2
  • DFP 0
  • Target Price
  • EBS $13.50
  • DFP N/A
  • AVG Volume (30 Days)
  • EBS 959.0K
  • DFP 56.2K
  • Earning Date
  • EBS 11-05-2025
  • DFP 01-01-0001
  • Dividend Yield
  • EBS N/A
  • DFP 6.73%
  • EPS Growth
  • EBS N/A
  • DFP N/A
  • EPS
  • EBS 2.53
  • DFP N/A
  • Revenue
  • EBS $851,600,000.00
  • DFP N/A
  • Revenue This Year
  • EBS N/A
  • DFP N/A
  • Revenue Next Year
  • EBS $19.24
  • DFP N/A
  • P/E Ratio
  • EBS $3.62
  • DFP N/A
  • Revenue Growth
  • EBS N/A
  • DFP N/A
  • 52 Week Low
  • EBS $4.02
  • DFP $15.45
  • 52 Week High
  • EBS $12.73
  • DFP $19.31
  • Technical
  • Relative Strength Index (RSI)
  • EBS 65.40
  • DFP 71.56
  • Support Level
  • EBS $8.58
  • DFP $21.57
  • Resistance Level
  • EBS $9.34
  • DFP $22.00
  • Average True Range (ATR)
  • EBS 0.38
  • DFP 0.13
  • MACD
  • EBS 0.10
  • DFP -0.02
  • Stochastic Oscillator
  • EBS 85.94
  • DFP 74.30

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.

Flaherty & Crumrine Dynamic Preferred and Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.

Share on Social Networks: